Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypes

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|232|2|142-150

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.232, Iss.2, 2014-01, pp. : 142-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 101-110

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Negative Breast Cancer: A Review

By  

Current Women's Health Reviews, Vol. 5, Iss. 3, 2009-01 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite

The role of the androgen receptor in triple-negative breast cancer

By Shah Payal D   Gucalp Ayca   Traina Tiffany A  

Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. : 351-360

Future Medicine

Access to resources Recommend Favorite

The Ethnic Profile of Triple-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 11, 2008-10 ,pp. : 580-582

Karger

Access to resources Recommend Favorite